Bayer Goodwill and Intangible Assets 2012-2025 | BAYRY

Bayer goodwill and intangible assets for the quarter ending December 31, 2025 were $55.080B, a 2.35% decline year-over-year.

  • Bayer goodwill and intangible assets for 2025 were $55.08B, a 2.35% decline from 2024.
  • Bayer goodwill and intangible assets for 2024 were $56.408B, a 6.37% decline from 2023.
  • Bayer goodwill and intangible assets for 2023 were $60.243B, a 10.42% decline from 2022.

Bayer Goodwill and Intangible Assets 2012-2025 | BAYRY

  • Bayer goodwill and intangible assets for 2025 were $55.08B, a 2.35% decline from 2024.
  • Bayer goodwill and intangible assets for 2024 were $56.408B, a 6.37% decline from 2023.
  • Bayer goodwill and intangible assets for 2023 were $60.243B, a 10.42% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Innoviva (INVA)$1.8B